Cardiology Institute of Rio Grande do Sul, Porto Alegre, Brazil.
JACC Cardiovasc Imaging. 2013 Nov;6(11):1141-51. doi: 10.1016/j.jcmg.2013.08.004. Epub 2013 Oct 2.
The aim of this study was to define the performance of lung ultrasound (LUS) compared with clinical assessment, natriuretic peptides, and echocardiography, to evaluate decompensation in patients with systolic heart failure (HF) in an outpatient clinic.
Evaluation of pulmonary congestion in chronic HF is challenging. LUS has been recently proposed as a reliable tool for the semiquantification of extravascular lung water through assessment of B-lines.
This was a cohort study of patients with moderate to severe systolic HF. Receiver-operating characteristic (ROC) analyses were performed to compare LUS with a previously validated clinical congestion score (CCS), amino-terminal portion of B-type natriuretic peptide (NT-proBNP), E/e' ratio, chest x-ray, and 6-min walk test.
Ninety-seven patients were enrolled. Decompensation was present in 57.7% of patients when estimated by CCS, 68% by LUS, 53.6% by NT-proBNP, and 65.3% by E/e' ≥15. The number of B-lines was correlated to NT-proBNP (r = 0.72; p < 0.0001), E/e' (r = 0.68; p < 0.0001), and CCS (r = 0.43; p < 0.0001). In ROC analyses, considering as reference for decompensation a combined method (E/e' ≥ 15 and/or NT-proBNP >1,000 pg/ml), LUS yielded a C-statistic of 0.89 (95% confidence interval: 0.82 to 0.96), providing the best accuracy with a cutoff ≥ 15 B-lines (sensitivity 85%, specificity 83%). A systematic approach using CCS, E/e', NT-proBNP, chest x-ray, and 6-min walk test in different combinations as reference for decompensation also corroborated this cutoff and found a similar accuracy for LUS.
In an HF outpatient clinic, B-lines were significantly correlated with more established parameters of decompensation. A B-line ≥15 cutoff could be considered for a quick and reliable assessment of decompensation in outpatients with HF.
本研究旨在定义肺部超声(LUS)与临床评估、利钠肽和超声心动图相比,在门诊评估收缩性心力衰竭(HF)患者失代偿时的表现。
评估慢性 HF 中的肺充血具有挑战性。LUS 最近被提出作为一种通过评估 B 线来半定量评估血管外肺水的可靠工具。
这是一项对中重度收缩性 HF 患者的队列研究。进行了受试者工作特征(ROC)分析,比较 LUS 与先前验证的临床充血评分(CCS)、氨基末端脑钠肽前体(NT-proBNP)、E/e' 比值、胸部 X 线和 6 分钟步行测试。
共纳入 97 例患者。根据 CCS 估计,57.7%的患者出现失代偿,根据 LUS 估计为 68%,根据 NT-proBNP 估计为 53.6%,根据 E/e'≥15 估计为 65.3%。B 线数量与 NT-proBNP(r = 0.72;p<0.0001)、E/e'(r = 0.68;p<0.0001)和 CCS(r = 0.43;p<0.0001)相关。在 ROC 分析中,将 E/e'≥15 和/或 NT-proBNP>1000pg/ml 的联合方法作为失代偿的参考,LUS 的 C 统计量为 0.89(95%置信区间:0.82 至 0.96),提供了最佳准确性,最佳截断值为≥15 条 B 线(敏感性 85%,特异性 83%)。使用 CCS、E/e'、NT-proBNP、胸部 X 线和 6 分钟步行测试的系统方法以不同组合作为失代偿的参考,也证实了这一切断值,并且发现 LUS 具有相似的准确性。
在 HF 门诊,B 线与更多已确立的失代偿参数显著相关。对于 HF 门诊患者的失代偿快速可靠评估,可考虑使用≥15 条 B 线的截断值。